Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity

Toxicology Letters

Volumn 137, Issue 1-2, 2003, Pages 85-93

  Baker, Jason R ^a   Satarug, Soisungwan ^a   Edwards, Robert J ^b   Moore, Michael R ^a,c   Williams, David J ^c   Reilly, Paul E B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c QUEENSLAND HEALTH   (Australia)

Author keywords

Cadmium toxicity; CYP4A11; Hypertension

Indexed keywords

CADMIUM; CYTOCHROME P450; CYTOCHROME P450 4A; ISOPROTEIN;

ADULT; AGED; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; EXPOSURE; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY; KIDNEY CORTEX; LIVER LEVEL; MALE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TISSUE LEVEL; TOXICITY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BODY BURDEN; CADMIUM; CADMIUM POISONING; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERTENSION; KIDNEY CORTEX; LIVER; MALE; MICROSOMES, LIVER; MIDDLE AGED;

EID: 12244250751     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00382-X     Document Type: Conference Paper

References (34)

1. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59:2000;95-104.
2. 2 induces the additional expression of metallothionein 1A mRNA. Toxicol. Lett. 76:1994;209-217.
3. Boobis A.R., Edwards R.J., Adams D.A., Davies D.S. Dissecting the function of cytochrome P450. Br. J. Clin. Pharmacol. 42:1996;81-89.
4. Capdevila J.H., Falck J.R., Harris R.C. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41:2000;163-181.
5. Eaton D.L., Stacey N.L., Wong K.-L., Klassen C.D. Dose-response effects of various metal ions on rat liver metallothionein, glutathione, heme oxygenase, and Cytochrome P-450. Toxicol. Appl. Pharmacol. 55:1980;393-402.
6. Edwards R.J., Adams D.A., Watts P.S., Davies D.S., Boobis A.R. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans. Biochem. Pharmacol. 56:1998;377-387.
7. Elinder C.G., Nordberg G. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand. J. Work Environ. Health. 24:1998;18-31.
8. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors ? and ? Proc. Natl. Acad. Sci. USA. 94:1997;4312-4317.
9. Foulkes E.C. The concept of critical levels of toxic heavy metals in target tissues. Crit. Rev. Tox. 20:1993;327-339.
10. 2+ induces metallothionein protein accumulation but not metallothionein isoform 2 mRNA. Environ. Health Perspect. 106:1998;587-595.
11. Guengerich F.P. Analysis and characterization of enzymes. Hayes A.W. Principles and Methods of Toxicology. 1994;1267-1268 Raven Press, New York.
12. Holla V.J., Adas F., Imig J.D., Zhao X., Price E., Olsen N., Kovacs W.J., Magnuson M.A., Keeney D.S., Breyer M.D., Falck J.R., Waterman M.R., Capdevila J.H. Alterations in the regulation of androgen-sensitive CYP 4a monooxygenases cause hypertension. Proc. Natl. Acad. Sci. USA. 98:2001;5211-5216.
13. Hsu M.-H., Palmer C.N.A., Song W., Griffin K.J., Johnson E.F. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J. Biol. Chem. 273:1998;27988-27997.
14. Iscan M., Karakaya A. Cadmium sensitivity differences between liver microsomal drug metabolizing enzyme systems of guinea-pig and rat. Comp. Biochem. Physiol. C. 90:1988;101-105.
15. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
16. Karin M., Haslinger A., Holtgreve H., Richards R.I., Krauter P., Westphal H.M., Beato M. Characterisation of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature. 308:1984;513-519.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Lasker J.M., Chen W.B., Wolf I., Bloswck B., Wilson P.D., Powell P.K. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney: role of CYP4F2 and CYP4A11. J. Biol. Chem. 275:2000;4118-4126.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Moreno C., Maier K.G., Hoagland K.M., Yu M., Roman R.J. Abnormal Pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid. Am. J. Hypertension. 14:2001;90s-97s.
21. Morgan H., Sherlock J.C. Cadmium intake and cadmium in the human kidney. Food Add. Contam. 1:1984;45-51.
22. Muerhoff A.S., Griffin K.J., Johnson E.F. The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ?-hydroxylase, by clofibric acid. J. Biol. Chem. 267:1992;19051-19053.
23. Petering D.H., Huang M., Moteki S., Shaw C.F. Cadmium and lead interactions with transcription factor IIIA from Xenopus laevis: a model for zinc finger protein reactions with toxic metal ions and metallothionein. Mar. Environ. Res. 50:(1-5):2000;89-92.
24. Powell P.K., Wolf I., Lasker J.M. Identification of CYP4A11 as the major lauric acid ?-hydroxylase in human liver microsomes. Arch. Biochem. Biophys. 335:1996;219-226.
25. Powell P.K., Wolf I., Jin R., Lasker J.M. Metabolism of arachidonic acid to 20-Hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J. Pharm. Exp. Ther. 285:1998;1327-1336.
26. Roman R.J., Maier J.K.G., Sun C.-W., Harder D.R., Alonso-Galicia M. Renal and Cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin. Exp. Pharmacol. Physiol. 27:2000;855-865.
27. Satarug S., Haswell-Elkins M.R., Moore M.R. Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br. J. Nutr. 84:2000;791-802.
28. Satarug S., Baker J.R., Reilly P.E.B., Moore M.R., Williams D.J. Changes in zinc and copper homeostasis in human livers and kidneys associated with exposure to environmental cadmium. Hum. Exp. Toxicol. 20:2001;205-213.
29. Schwartzman M.L., Martasec P., Rios A.R., Lever R.D., Solangi K., Goodman A.I., Abraham N.G. Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int. 37:1990;94-99.
30. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA. 61:1968;748-755.
31. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
32. Tully D.B., Collins B.J., Overstreet J.D., Smith C.S., Dinse G.E., Mumtaz M.M., Chapin R.E. Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol. Appl. Pharmacol. 168:2000;79-90.
33. Yoshinaga J. Analysis of metals in human tissues. Massaro E.J. Handbook of Human Toxicology. 1997;18-22 CRC Press, New York.
34. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276:(39):2001;36059-36062.